86487-53-8 Usage
Explanation
This is the chemical name of the compound, which is derived from its structural formula.
Explanation
Zaleplon is the commonly used name for this chemical compound.
3. Psychoactive drug
Explanation
Zaleplon is a psychoactive drug, meaning it affects the central nervous system and alters brain function.
Explanation
Zaleplon is primarily used to treat insomnia, helping individuals with sleep disturbances.
Explanation
Zaleplon belongs to a class of drugs called nonbenzodiazepines, which are different from benzodiazepines in their chemical structure and mechanism of action.
Explanation
Zaleplon is further classified under the pyrazolopyrimidines subclass, which are a group of nonbenzodiazepine drugs.
Explanation
Zaleplon acts as a selective agonist, meaning it specifically binds to and activates the omega-1 (α1) subunit of the gamma-aminobutyric acid-A (GABAA) receptor in the brain, which helps regulate sleep and relaxation.
Explanation
Zaleplon has a short half-life, meaning it is quickly metabolized and eliminated from the body, which contributes to its rapid onset of action and minimal residual effects.
Explanation
Zaleplon has a rapid onset of action, allowing individuals to experience its sleep-inducing effects quickly.
Explanation
Due to its short half-life, zaleplon has minimal residual effects, reducing the likelihood of next-day drowsiness or other side effects.
Explanation
Like other sedative-hypnotic drugs, zaleplon carries the risk of developing tolerance (needing higher doses for the same effect), dependence (requiring the drug to feel normal), and experiencing withdrawal symptoms (unpleasant physical or mental effects when stopping the drug) if used improperly.
Explanation
Zaleplon should be used with caution and under the guidance of a healthcare professional to minimize the risks associated with its use.
Use
Insomnia treatment
Drug class
Nonbenzodiazepine drugs
Subclass
Pyrazolopyrimidines
Mechanism of action
Selective agonist at the omega-1 (α1) subunit of the GABAA receptor
Half-life
Short
Onset of action
Rapid
Residual effects
Minimal
Risks
Tolerance, dependence, and withdrawal symptoms
Professional guidance
Caution and healthcare supervision
Check Digit Verification of cas no
The CAS Registry Mumber 86487-53-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,4,8 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 86487-53:
(7*8)+(6*6)+(5*4)+(4*8)+(3*7)+(2*5)+(1*3)=178
178 % 10 = 8
So 86487-53-8 is a valid CAS Registry Number.
86487-53-8Relevant academic research and scientific papers
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
-
, (2008/06/13)
3-Piperdinyl-1,2-benzisothiazoles and 3-piperidinyl-1,2-benzisoxazoles and their pharmaceutically acceptable acid addition salts having useful antipsychotic properties and being useful in the treatment of a variety of complaints in which serotonin release is of predominant importance.
[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
-
, (2008/06/13)
Novel [[bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones, wherein the pyrimidinone-ring is embraced within a bicyclic system, being useful compounds in the treatment of psychosomatic disorders.
Bicyclic pyrimidin-5-one derivatives
-
, (2008/06/13)
Novel 5H-thiazolo- and 5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one and 3,4-dihydro-2H,6H-pyrimido[2,1-b] [1,3]-thiazin-6-one derivatives, which compounds are useful psychotropic agents.
